Immunohistochemical analysis of Claudin-5 in IBMs treated with NMO-IgG1 showed that Claudin-5 was still present within an apparent normal junctional localization in the microvascular network (data not shown). The gene discussed is CLDN5; the disease is neuromyelitis optica.